About this trial
Heart rhythm disorders are common and significantly impact the lives of those affected and their families. The main problems can be categorized as: a) atrial fibrillation or AF and atrial flutter, b) supra-ventricular tachycardia or SVT, c) excessively slow heart beats (i.e., bradycardia or pauses) and d) ventricular arrhythmias. These problems can be difficult to detect with currently available monitoring options as they are all worn for shorter terms or are an invasive implantable option. The HeartWatch is a longer term monitoring system that is worn on the upper arm, allows users to create a tag and pairs with an app on a smartphone allowing for correlation of symptoms.
Eligibility criteria
Qualifiers
At least 22 years of age at time of consent
Clinically indicated for a Holter monitor test
Able to wear the HeartWatch on the left bicep for the study duration
Able to follow the protocol
Disqualifiers
Known allergy to any component of the Holter monitor
Known allergy to any component of the HeartWatch
Inability to wear the HeartWatch on the left arm for the study period due to pre-existing medical condition (3.g., functional AV fistula in left arm, prior carcinoma with lymph node dissection or lymphedema, known blood clot of recurrent blood clots in the left arm, chronic neuropathic pain in left arm, ...)
Dextrocardia
Trial design
Treatments tested in this trial
- HeartWatch